The role of geroscience in understanding Alzheimer’s Disease

For more than 30 years, researchers have identified and quantified genetic and lifestyle factors for Alzheimer’s Disease (AD) and other dementias. Despite extensive research, the fundamental mechanisms behind these neurodegenerative diseases are still not fully understood, and effective management of AD is taking longer than expected.

Verizon Deploys 5G Edge to Advance Care at VA Palo Alto Medical Center

What You Should Know: Verizon Business, in partnership with the VA Palo Alto Health Care System today announced the deployment of a full spectrum private 5G network. This

July 27, 2023

FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug

Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus,

September 13, 2024

Takeda’s FRUZAQLA gains approval in Japan for colorectal cancer

FRUZAQLA is intended for patients with CRC that has progressed following chemotherapy. Credit: SewCreamStudio/Shutterstock. Takeda has secured approval from the Japanese Ministry of Health, Labour

September 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.